Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Cysic Cysic +20.83%
#4 Bedrock Bedrock +18.46%
#5 Nockchain Nockchain +16.07%
#6 Velvet Velvet +14.00%
#7 Fabric Protocol Fabric Protocol +13.90%
#8 Perle Perle +12.76%
#9 Starpower Starpower +12.51%
#10 Nillion Nillion +12.50%
Coin of the day
EXOD EXOD
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Classificação em ações #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Preço da ação
$0.00060315
Última sincronização: 2024-09-27
Valor de mercado
$1.65M
Variação (1 dia)
19.64%
Variação (1 ano)
0.00%
País
SE
Negociar Amniotics AB (publ) (AMNI)

Categoria

Healthcare
EPS de Amniotics AB (publ) (AMNI)
EPS em December 2023 TTM: $-0.04
De acordo com os últimos relatórios financeiros e o preço das ações da Amniotics AB (publ), o EPS atual da empresa (TTM) é $-0.04. No final de 2022, a empresa teve um EPS de $-0.03, uma diminuição em relação a ao EPS de 2021, que foi de $-0.04.
Histórico de EPS da Amniotics AB (publ) de 2018 até 2026
EPS no final de cada ano
Ano EPS Alterar
2026 (TTM) $-0.04 -96.18%
2023 0.00 -96.18%
2022 $-0.03 -21.10%
2021 $-0.04 77.18%
2020 $-0.02 237.70%
2019 $-0.01 45.24%
2018 0.00 0.00%
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -47,293.46%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -75,685.83%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -37,429.97%
BE